SuperGen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 10, 2008
November 03 2008 - 8:00AM
PR Newswire (US)
SuperGen, Inc. (NASDAQ: SUPG), a pharmaceutical company dedicated
to the discovery and development of novel cancer therapies, today
announced that James S. Manuso, Ph.D., President and Chief
Executive Offer, is scheduled to present at the Rodman &
Renshaw 10th Annual Healthcare Conference on Monday, November 10,
2008, at the New York Palace Hotel. SuperGen's presentation at the
Rodman & Renshaw 10th Annual Healthcare Conference is scheduled
to begin at 11:35 a.m. EDT (8:35 a.m. PDT). A live webcast of the
presentation will be available on the investor relations section of
the Company's Web site at http://www.supergen.com/. The webcast
will be archived for 90 days. About SuperGen Based in Dublin,
Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the
discovery and development of novel cancer therapies. SuperGen is
developing a number of therapeutic anticancer products focused on
kinase and cell signaling inhibitors and DNA methyltransferase
inhibitors. For more information about SuperGen, please visit
http://www.supergen.com/. Contacts: SuperGen, Inc. Timothy L. Enns
SVP, Corporate Communications & Business Development Tel: (925)
560-0100 Email: Mary M. Vegh Manager, Investor Relations Tel: (925)
560-2845 E-mail: Dorland Global Public Relations Michael Beckerich
(Media) Tel: (212) 677-7632 DATASOURCE: SuperGen, Inc. CONTACT:
Timothy L. Enns, SVP of Corporate Communications & Business
Development, +1-925-560-0100, , or Mary M. Vegh, Manager, Investor
Relations, +1-925-560-2845, , both of SuperGen, Inc., or Michael
Beckerich of Dorland Global Public Relations, +1-212-677-7632, Web
Site: http://www.supergen.com/
Copyright